Cargando…

Comparison of Calcaneal Subchondral Injection of Calcium Phosphate and Plantar Fasciotomy vs Plantar Fasciotomy Alone for Refractory Infracalcaneal Heel Pain

BACKGROUND: Treatment of chronic refractory heel pain has evolved to consider calcaneal structural fatigue as a component of the symptom profile. While concomitant calcium phosphate injection has become a method of addressing the accompanying calcaneal bone marrow edema (BME) frequently seen in this...

Descripción completa

Detalles Bibliográficos
Autores principales: Matthews, Michael, Klein, Erin, Hulst, Zachary, Patel, Neathie, Weil, Lowell, Sorensen, Matthew, Fleischer, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558602/
https://www.ncbi.nlm.nih.gov/pubmed/35097479
http://dx.doi.org/10.1177/24730114211050568
_version_ 1784592600515215360
author Matthews, Michael
Klein, Erin
Hulst, Zachary
Patel, Neathie
Weil, Lowell
Sorensen, Matthew
Fleischer, Adam
author_facet Matthews, Michael
Klein, Erin
Hulst, Zachary
Patel, Neathie
Weil, Lowell
Sorensen, Matthew
Fleischer, Adam
author_sort Matthews, Michael
collection PubMed
description BACKGROUND: Treatment of chronic refractory heel pain has evolved to consider calcaneal structural fatigue as a component of the symptom profile. While concomitant calcium phosphate injection has become a method of addressing the accompanying calcaneal bone marrow edema (BME) frequently seen in this population, there is no literature supporting its use compared to traditional fasciotomy. METHODS: Consecutive patients with symptoms of refractory infracalcaneal heel pain and calcaneal BME were treated in our practice by either surgical fasciotomy (n = 33) or fasciotomy plus calcium phosphate injection (n = 31) between 2014 and 2019. Outcomes were retrospectively assessed via Foot and Ankle Outcome Scores (FAOS), return to activity, and complication rate. RESULTS: Sixty-four patients (64 feet) were included with a mean age of 50.3 ± 12.9 years and mean follow-up of 23.2 ± 22.3 months. No differences were observed between groups preoperatively. Significant improvements in 4 of 5 FAOS subscales were observed postoperatively in both groups (P < .05 for all, paired t test). However, patients undergoing concomitant calcium phosphate injection reported significantly better scores for both activities of daily living (ADL; mean difference +10.2; 95% confidence interval [CI] 0.07-20.2) and foot-specific QOL (mean difference +21.9, 95% CI 7.0-36.6) at final follow-up compared with those undergoing plantar fasciotomy alone. All patients returned to their desired level of activity, and the frequency of complications did not differ between groups (P > .05, Fisher exact test). CONCLUSION: In patients presenting with recalcitrant infracalcaneal heel pain accompanied by calcaneal BME, calcium phosphate injection into the calcaneus, when combined with plantar fasciotomy, was safe and more effective than traditional plantar fasciotomy alone. LEVEL OF EVIDENCE: Level III, retrospective comparative study.
format Online
Article
Text
id pubmed-8558602
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-85586022022-01-28 Comparison of Calcaneal Subchondral Injection of Calcium Phosphate and Plantar Fasciotomy vs Plantar Fasciotomy Alone for Refractory Infracalcaneal Heel Pain Matthews, Michael Klein, Erin Hulst, Zachary Patel, Neathie Weil, Lowell Sorensen, Matthew Fleischer, Adam Foot Ankle Orthop Article BACKGROUND: Treatment of chronic refractory heel pain has evolved to consider calcaneal structural fatigue as a component of the symptom profile. While concomitant calcium phosphate injection has become a method of addressing the accompanying calcaneal bone marrow edema (BME) frequently seen in this population, there is no literature supporting its use compared to traditional fasciotomy. METHODS: Consecutive patients with symptoms of refractory infracalcaneal heel pain and calcaneal BME were treated in our practice by either surgical fasciotomy (n = 33) or fasciotomy plus calcium phosphate injection (n = 31) between 2014 and 2019. Outcomes were retrospectively assessed via Foot and Ankle Outcome Scores (FAOS), return to activity, and complication rate. RESULTS: Sixty-four patients (64 feet) were included with a mean age of 50.3 ± 12.9 years and mean follow-up of 23.2 ± 22.3 months. No differences were observed between groups preoperatively. Significant improvements in 4 of 5 FAOS subscales were observed postoperatively in both groups (P < .05 for all, paired t test). However, patients undergoing concomitant calcium phosphate injection reported significantly better scores for both activities of daily living (ADL; mean difference +10.2; 95% confidence interval [CI] 0.07-20.2) and foot-specific QOL (mean difference +21.9, 95% CI 7.0-36.6) at final follow-up compared with those undergoing plantar fasciotomy alone. All patients returned to their desired level of activity, and the frequency of complications did not differ between groups (P > .05, Fisher exact test). CONCLUSION: In patients presenting with recalcitrant infracalcaneal heel pain accompanied by calcaneal BME, calcium phosphate injection into the calcaneus, when combined with plantar fasciotomy, was safe and more effective than traditional plantar fasciotomy alone. LEVEL OF EVIDENCE: Level III, retrospective comparative study. SAGE Publications 2021-10-28 /pmc/articles/PMC8558602/ /pubmed/35097479 http://dx.doi.org/10.1177/24730114211050568 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Article
Matthews, Michael
Klein, Erin
Hulst, Zachary
Patel, Neathie
Weil, Lowell
Sorensen, Matthew
Fleischer, Adam
Comparison of Calcaneal Subchondral Injection of Calcium Phosphate and Plantar Fasciotomy vs Plantar Fasciotomy Alone for Refractory Infracalcaneal Heel Pain
title Comparison of Calcaneal Subchondral Injection of Calcium Phosphate and Plantar Fasciotomy vs Plantar Fasciotomy Alone for Refractory Infracalcaneal Heel Pain
title_full Comparison of Calcaneal Subchondral Injection of Calcium Phosphate and Plantar Fasciotomy vs Plantar Fasciotomy Alone for Refractory Infracalcaneal Heel Pain
title_fullStr Comparison of Calcaneal Subchondral Injection of Calcium Phosphate and Plantar Fasciotomy vs Plantar Fasciotomy Alone for Refractory Infracalcaneal Heel Pain
title_full_unstemmed Comparison of Calcaneal Subchondral Injection of Calcium Phosphate and Plantar Fasciotomy vs Plantar Fasciotomy Alone for Refractory Infracalcaneal Heel Pain
title_short Comparison of Calcaneal Subchondral Injection of Calcium Phosphate and Plantar Fasciotomy vs Plantar Fasciotomy Alone for Refractory Infracalcaneal Heel Pain
title_sort comparison of calcaneal subchondral injection of calcium phosphate and plantar fasciotomy vs plantar fasciotomy alone for refractory infracalcaneal heel pain
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558602/
https://www.ncbi.nlm.nih.gov/pubmed/35097479
http://dx.doi.org/10.1177/24730114211050568
work_keys_str_mv AT matthewsmichael comparisonofcalcanealsubchondralinjectionofcalciumphosphateandplantarfasciotomyvsplantarfasciotomyaloneforrefractoryinfracalcanealheelpain
AT kleinerin comparisonofcalcanealsubchondralinjectionofcalciumphosphateandplantarfasciotomyvsplantarfasciotomyaloneforrefractoryinfracalcanealheelpain
AT hulstzachary comparisonofcalcanealsubchondralinjectionofcalciumphosphateandplantarfasciotomyvsplantarfasciotomyaloneforrefractoryinfracalcanealheelpain
AT patelneathie comparisonofcalcanealsubchondralinjectionofcalciumphosphateandplantarfasciotomyvsplantarfasciotomyaloneforrefractoryinfracalcanealheelpain
AT weillowell comparisonofcalcanealsubchondralinjectionofcalciumphosphateandplantarfasciotomyvsplantarfasciotomyaloneforrefractoryinfracalcanealheelpain
AT sorensenmatthew comparisonofcalcanealsubchondralinjectionofcalciumphosphateandplantarfasciotomyvsplantarfasciotomyaloneforrefractoryinfracalcanealheelpain
AT fleischeradam comparisonofcalcanealsubchondralinjectionofcalciumphosphateandplantarfasciotomyvsplantarfasciotomyaloneforrefractoryinfracalcanealheelpain